tiprankstipranks
Trending News
More News >
Compumedics Limited (AU:CMP)
ASX:CMP
Australian Market
Advertisement

Compumedics Limited (CMP) Stock Statistics & Valuation Metrics

Compare
4 Followers

Total Valuation

Compumedics Limited has a market cap or net worth of AU$60.55M. The enterprise value is AU$60.20M.
Market CapAU$60.55M
Enterprise ValueAU$60.20M

Share Statistics

Compumedics Limited has 192,217,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding192,217,900
Owned by Insiders
Owned by Institutions

Financial Efficiency

Compumedics Limited’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is 4.26%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)4.26%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee329.29K
Profits Per Employee-8.21K
Employee Count155
Asset Turnover0.94
Inventory Turnover1.37

Valuation Ratios

The current PE Ratio of Compumedics Limited is ―. Compumedics Limited’s PEG ratio is -0.14.
PE Ratio
PS Ratio0.91
PB Ratio2.12
Price to Fair Value2.12
Price to FCF99.22
Price to Operating Cash Flow75.77
PEG Ratio-0.14

Income Statement

In the last 12 months, Compumedics Limited had revenue of 51.04M and earned -1.27M in profits. Earnings per share was -0.01.
Revenue51.04M
Gross Profit30.99M
Operating Income714.00K
Pretax Income-593.00K
Net Income-1.27M
EBITDA1.94M
Earnings Per Share (EPS)-0.01

Cash Flow

In the last 12 months, operating cash flow was 681.00K and capital expenditures -214.00K, giving a free cash flow of 467.00K billion.
Operating Cash Flow681.00K
Free Cash Flow467.00K
Free Cash Flow per Share<0.01

Dividends & Yields

Compumedics Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.98
52-Week Price Change13.33%
50-Day Moving Average0.30
200-Day Moving Average0.29
Relative Strength Index (RSI)58.75
Average Volume (3m)98.48K

Important Dates

Compumedics Limited upcoming earnings date is Mar 3, 2026, TBA (Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateMar 3, 2026
Ex-Dividend Date

Financial Position

Compumedics Limited as a current ratio of 1.10, with Debt / Equity ratio of 63.60%
Current Ratio1.10
Quick Ratio0.64
Debt to Market Cap0.28
Net Debt to EBITDA5.77
Interest Coverage Ratio0.56

Taxes

In the past 12 months, Compumedics Limited has paid 679.00K in taxes.
Income Tax679.00K
Effective Tax Rate-1.15

Enterprise Valuation

Compumedics Limited EV to EBITDA ratio is 29.67, with an EV/FCF ratio of 123.18.
EV to Sales1.13
EV to EBITDA29.67
EV to Free Cash Flow123.18
EV to Operating Cash Flow84.47

Balance Sheet

Compumedics Limited has AU$2.69M in cash and marketable securities with AU$13.88M in debt, giving a net cash position of -AU$11.19M billion.
Cash & Marketable SecuritiesAU$2.69M
Total DebtAU$13.88M
Net Cash-AU$11.19M
Net Cash Per Share-AU$0.06
Tangible Book Value Per ShareAU$0.03

Margins

Gross margin is 60.71%, with operating margin of 1.40%, and net profit margin of -2.49%.
Gross Margin60.71%
Operating Margin1.40%
Pretax Margin-1.16%
Net Profit Margin-2.49%
EBITDA Margin3.80%
EBIT Margin1.40%

Analyst Forecast

The average price target for Compumedics Limited is AU$0.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetAU$0.50
Price Target Upside47.06% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast2.23%
EPS Growth Forecast-263.16%

Scores

Smart Score4
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis